Accéder au contenu
Merck

Exploration of novel predictive markers in rat plasma of the early stages of chronic renal failure.

Analytical and bioanalytical chemistry (2013-11-16)
Toshihiro Kobayashi, Yuriko Matsumura, Toshihiko Ozawa, Hiroyuki Yanai, Atsuo Iwasawa, Toshiaki Kamachi, Kouichi Fujiwara, Noriaki Tanaka, Masahiro Kohno
RÉSUMÉ

To identify blood markers for early stages of chronic kidney disease (CKD), blood samples were collected from rats with adenine-induced CKD over 28 days. Plasma samples were subjected to metabolomic profiling by liquid chromatography-mass spectrometry, followed by multivariate analyses. In addition to already-identified uremic toxins, we found that plasma concentrations of N6-succinyl adenosine, lysophosphatidylethanolamine 20:4, and glycocholic acid were altered, and that these changes during early CKD were more sensitive markers than creatinine concentration, a universal indicator of renal dysfunction. Moreover, the increase in plasma indoxyl sulfate concentration occurred earlier than increases in phenyl sulfate and p-cresol sulfate. These novel metabolites may serve as biomarkers in identifying early stage CKD.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Adénine, ≥99%